MedTrace Logo

Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women

NCT00362375 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 313

Last updated 2010-05-14

Study results available
· View outcomes & findings →

Summary

The purpose of this program evaluation is to determine whether the Health Love Workshop, a group-level HIV behavioral intervention, reduces HIV-related sex risk behaviors and increases HIV protective behaviors of African American women and women of African descent. The intent of this program is to support an evaluation of the efficacy of the intervention and to provide feedback to the implementing organization to increase intervention effectiveness.

Conditions

  • HIV Infections
  • Sexually Transmitted Infections

Interventions

BEHAVIORAL

Healthy Love Workshop

The Healthy Love Workshop is a single-session intervention lasting 3-4 h that is typically delivered to groups of 4-15 women; however, SisterLove facilitators can accommodate larger groups if needed. The intervention is designed to increase consistent use of condoms and other latex barriers, reduce unprotected sex with male partners, and reduce the number of sex partners. HLW also promotes sexual abstinence, HIV testing, and receipt of test results.

BEHAVIORAL

HIV/AIDS 101 Workshop

The comparison workshop (named HIV101) was also delivered as a single session lasting 2-3 h, to groups of women about the same size and in settings similar to those used for the HLW. The HIV101 workshop consists of an opening, one module containing the same three HIV/STD-related components as the HLW (HIV/AIDS facts, STI facts, and the Look of HIV) and a closing. However, the presentation of this information used a didactic, lecture-style format, as opposed to the interactive approach used to deliver the HLW.

Sponsors & Collaborators

Principal Investigators

  • Dazon Dixon Diallo, MPH · President/CEO SisterLove, Inc.

  • Jeffrey H Herbst, PhD · Project Officer, Division of HIV/AIDS Prevention, NCHHSTP, CDC

  • Thomas M Painter, PhD · Project Officer, Division of HIV/AIDS Prevention, NCHHSTP, CDC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00362375 on ClinicalTrials.gov